Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Balancing cost-effectiveness with individual tolerance and side-effects ensures that treatment decisions reflect both clinical outcomes and quality-of-life considerations
Over the course of several weeks, the dosage gradually increases until reaching the maintenance dose of 2.4 mg weekly
Tirzepatide does not have a known direct mechanism of action on the vascular or neurological pathways specifically involved in erectile function
Among Americans, the average age of respondents was 41
AI is enhancing performance and even scouting future talent in elite sport
In laboratory and pre-clinical settings, PT-141 (Bremelanotide) is studied as the defining CNS melanocortin agonist for sexual behaviour neuroscience and melanocortin receptor pharmacology: MC4R pharmacology receptor binding kinetics, Gs/cAMP/PKA signalling, hypothalamic expression mapping, and MC4R-selective research design Melanocortin receptor profiling MC1R/MC3R/MC4R/MC5R binding affinity, SAR studies, and MCR subtype selectivity research Central sexual behaviour neuroscience mPOA and PVN neuronal activation, c-Fos immunoreactivity, and hypothalamic circuit mapping Dopamine system modulation mPOA dopamine release, nucleus accumbens reward integration, and monoaminergic neurotransmitter crosstalk Oxytocin circuit activation PVN oxytocin neuron stimulation and affective/bonding dimension of sexual response HSDD research models female sexual desire deficiency models, melanocortin excitatory pathway engagement, and excitation/inhibition balance Erectile dysfunction research MC4R-mediated erectile pathway, PVN-corpus cavernosum neural connectivity, and PDE5-independent erection modelling CNS vs peripheral mechanism dissection central melanocortin pathway vs nitric oxide/PDE5 axis
US$ 24.42
US$ 27.51
US$ 26.89
US$ 25.76
